“NACI Recommends Supemtek Quadrivalent Influenza Vaccine for Adults”

https://pubmed.ncbi.nlm.nih.gov/38116047

The National Advisory Committee on Immunization (NACI) recommends that Supemtek, a recombinant quadrivalent influenza vaccine, may be considered for annual influenza vaccination in adults 18 years and older due to its fair effectiveness, safety, and non-inferior immunogenicity compared to conventional egg-based vaccines.